Study of the Safety and Efficacy of Roxadustat in the Treatment of Heart Failure With Chronic Kidney Disease and Anemia

NCT05691257 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure
Chronic Kidney Diseases
Anemia

Interventions

DRUG: Roxadustat
DRUG: Recombinant human eythropoietin and/or Iron agents

Sponsor

China-Japan Friendship Hospital